Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovidrel × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Completed 3 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

pembrolizumab 506 Specimen Handling 418 Carboplatin 381 Magnetic Resonance Spectroscopy 375 Cisplatin 357 Cyclophosphamide 342 Radiotherapy 312 Gemcitabine 268 Bevacizumab 263 Paclitaxel 253 Biopsy 244 Drug Therapy 239 Blood Specimen Collection 213 venetoclax 200 Nivolumab 200 fludarabine 199 Capecitabine 194 Oxaliplatin 189 Docetaxel 183 Injections 176 Fluorouracil 168 Radiosurgery 156 Dexamethasone 156 Pemetrexed 140 Rituximab 137 Standard of Care 134 Surgical Procedures, Operative 127 durvalumab 126 atezolizumab 124 tislelizumab 120

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03905603 2023-11-03

SHK001

University of Virginia

Phase EARLY_PHASE1 Recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡